Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02355613
Other study ID # 1268
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 15, 2014
Est. completion date July 2021

Study information

Verified date May 2022
Source Istituto Clinico Humanitas
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized double arm phase III study to evaluate feasibility and safety of Gamma Knife radiosurgery and Linac Based (Edge) radiosurgery in brain metastatic patients


Description:

This is a prospective double arm phase III study to evaluate cerebral side effects following radiosurgery delivered by Gamma Knife Perfexion and Linac Based EDGE. In particular our primary objective is to evaluate rate of symptomatic radionecrosis from the two different modalities of radiosurgery.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date July 2021
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: - Age 18 - 85 years - 1 - 4 brain metastases - Karnofsky performance status (KPS) =70 - RPA 1 or 2 - Histopathologically confirmation of primary solid tumor - Estimated survival = 3 months as GPA score - Written informed consent Exclusion Criteria: - Prior WBRT - Age > 85 years - KPS < 70 - RPA 3 - Diagnosis of small cell lung cancer (SCLC) or Lymphoproliferative disease - Use of Avastin for at least 2 months after radiosurgery - Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Radiation:
Radiosurgery with Gamma Knife Perfexion
Gamma Knife Radiosurgery is a very precise form of therapeutic radiology. Even though it is called surgery, a Gamma Knife procedure does not involve actual surgery but it uses 192 isocentric beams of highly-focused gamma rays (60-Co) to treat small to medium size lesions. Minimum beam size is 4 mm. This procedure is frame based.
Linac-based Radiosurgery with EDGE
EDGE linear accelerator from Varian (Varian, Palo Alto, USA) is a C-arm machine specifically developed for radiosurgery frameless treatment. The characteristics of this linac are a high level of precision and the possibility to include multiple positioning systems for stereotactical treatments, among which Cone Beam CT (CBCT), the Optical Surface Monitoring System (OSMS), and Calypso.

Locations

Country Name City State
Italy Istituto Clinico Humanitas Rozzano MI

Sponsors (1)

Lead Sponsor Collaborator
Istituto Clinico Humanitas

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of symptomatic radionecrosis two years
Secondary Local Control of Brain Metastases two years
Secondary Disease Free survival two years
Secondary Overall survival two years
See also
  Status Clinical Trial Phase
Recruiting NCT05474573 - Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases N/A
Recruiting NCT05485038 - General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas N/A
Recruiting NCT05475522 - Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases N/A